{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T13:28:13Z","timestamp":1768483693674,"version":"3.49.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["1R01AR068897-01A1"],"award-info":[{"award-number":["1R01AR068897-01A1"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["2P01 AR-05235"],"award-info":[{"award-number":["2P01 AR-05235"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012500","name":"Palmerston North Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012500","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001136","name":"Australian and New Zealand College of Anaesthetists","doi-asserted-by":"publisher","award":["15\/011"],"award-info":[{"award-number":["15\/011"]}],"id":[{"id":"10.13039\/501100001136","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001136","name":"Australian and New Zealand College of Anaesthetists","doi-asserted-by":"publisher","award":["20\/001"],"award-info":[{"award-number":["20\/001"]}],"id":[{"id":"10.13039\/501100001136","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001554","name":"Massey University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bjanaesthesia.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["British Journal of Anaesthesia"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.bja.2022.08.029","type":"journal-article","created":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T00:20:29Z","timestamp":1665015629000},"page":"879-888","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Functional analysis of RYR1 variants in patients with confirmed susceptibility to malignant hyperthermia"],"prefix":"10.1016","volume":"129","author":[{"given":"Ruth","family":"White","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4660-0979","authenticated-orcid":false,"given":"Anja H.","family":"Schiemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie M.","family":"Burling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Bjorksten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terasa","family":"Bulger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5057-0349","authenticated-orcid":false,"given":"Robyn","family":"Gillies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip M.","family":"Hopkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik-Jan","family":"Kamsteeg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roslyn G.","family":"Machon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean","family":"Massey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorota","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Perry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc M.J.","family":"Snoeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy","family":"Stephens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil","family":"Street","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luuk R.","family":"van den Bersselaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn M.","family":"Stowell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bja.2022.08.029_bib1","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1749-6632.1993.tb38060.x","article-title":"The role of the calcium release channel of skeletal muscle sarcoplasmic reticulum in malignant hyperthermia","volume":"707","author":"MacLennan","year":"1993","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.bja.2022.08.029_bib2","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/bja\/aev225","article-title":"European Malignant Hyperthermia Group guidelines for investigation of malignant hyperthermia susceptibility","volume":"115","author":"Hopkins","year":"2015","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2022.08.029_bib3","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/bja\/86.2.283","article-title":"Guidelines for molecular genetic detection of susceptibility to malignant hyperthermia","volume":"86","author":"Urwyler","year":"2001","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2022.08.029_bib4","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.bbamcr.2018.12.004","article-title":"STAC proteins: the missing link in skeletal muscle EC coupling and new regulators of calcium channel function","volume":"7","author":"Flucher","year":"2019","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"10.1016\/j.bja.2022.08.029_bib5","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1055\/s-0037-1601868","article-title":"Novel STAC3 mutations in the first non-Amerindian patient with Native American myopathy","volume":"48","author":"Grzybowski","year":"2017","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.bja.2022.08.029_bib6","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1038\/ncomms2952","article-title":"Stac3 is a component of the excitation-contraction coupling machinery and mutated in Native American myopathy","volume":"4","author":"Horstick","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.bja.2022.08.029_bib7","doi-asserted-by":"crossref","first-page":"10986","DOI":"10.1073\/pnas.1612441113","article-title":"Stac3 has a direct role in skeletal muscle-type excitation-contraction coupling that is disrupted by a myopathy-causing mutation","volume":"113","author":"Polster","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bja.2022.08.029_bib8","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1002\/ajmg.a.38375","article-title":"Identification of\u00a0STAC3 variants in non-Native American families with\u00a0overlapping features of Carey\u2013Fineman\u2013Ziter syndrome and Moebius syndrome","volume":"173","author":"Telegrafi","year":"2017","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.bja.2022.08.029_bib9","doi-asserted-by":"crossref","first-page":"C323","DOI":"10.1152\/ajpcell.00187.2017","article-title":"Functional and structural characterization of a novel malignant hyperthermia-susceptible variant of DHPR-\u03b21a subunit (CACNB1)","volume":"314","author":"Perez","year":"2018","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.bja.2022.08.029_bib10","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1177\/0310057X1604400625","article-title":"Sequencing of genes involved in the movement of calcium across human skeletal muscle sarcoplasmic reticulum: continuing the search for genes associated with malignant hyperthermia","volume":"44","author":"Bjorksten","year":"2016","journal-title":"Anaesthest Intensive Care"},{"key":"10.1016\/j.bja.2022.08.029_bib11","doi-asserted-by":"crossref","first-page":"d671","DOI":"10.2741\/ikemoto","article-title":"Regulation of calcium release by interdomain interaction within ryanodine receptors","volume":"7","author":"Ikemoto","year":"2002","journal-title":"Front Biosci"},{"key":"10.1016\/j.bja.2022.08.029_bib12","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/BF01788371","article-title":"Dihydropyridine receptor-ryanodine receptor interactions in skeletal muscle excitation-contraction coupling","volume":"15","author":"Meissner","year":"1995","journal-title":"Biosci Rep"},{"key":"10.1016\/j.bja.2022.08.029_bib13","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1016\/S0006-3495(02)75325-3","article-title":"Multiple regions of RyR1 mediate functional and structural interactions with alpha(1S)-dihydropyridine receptors in skeletal muscle","volume":"83","author":"Protasi","year":"2002","journal-title":"Biophys J"},{"key":"10.1016\/j.bja.2022.08.029_bib14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1023\/A:1019984714528","article-title":"Calcium regulation and muscle disease","volume":"23","author":"Gommans","year":"2002","journal-title":"J\u00a0Muscle Res Cell Motil"},{"key":"10.1016\/j.bja.2022.08.029_bib15","doi-asserted-by":"crossref","first-page":"26332","DOI":"10.1074\/jbc.272.42.26332","article-title":"Caffeine and halothane sensitivity of intracellular Ca2+ release is altered by 15 calcium release channel (ryanodine receptor) mutations associated with malignant hyperthermia and\/or central core disease","volume":"272","author":"Tong","year":"1997","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.bja.2022.08.029_bib16","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1254\/jjp.88.159","article-title":"Novel mutations in C-terminal channel region of the ryanodine receptor in malignant hyperthermia patients","volume":"88","author":"Oyamada","year":"2002","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.bja.2022.08.029_bib17","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00000542-200308000-00011","article-title":"Detection of a novel ryanodine receptor subtype 1 mutation (R328W) in a malignant hyperthermia family by sequencing of a leukocyte transcript","volume":"99","author":"Loke","year":"2003","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2022.08.029_bib18","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1042\/bj3340079","article-title":"Expression of ryanodine receptors in human embryonic kidney (HEK293) cells","volume":"334","author":"Querfurth","year":"1998","journal-title":"Biochem J"},{"key":"10.1016\/j.bja.2022.08.029_bib19","first-page":"147","article-title":"Functional characterization of C-terminal ryanodine receptor 1 variants associated with central core disease or malignant hyperthermia","volume":"4","author":"Parker","year":"2017","journal-title":"J\u00a0Neuromuscul Dis"},{"key":"10.1016\/j.bja.2022.08.029_bib20","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ceca.2014.07.004","article-title":"Functional characterisation of the R2452W ryanodine receptor variant associated with malignant hyperthermia susceptibility","volume":"56","author":"Roesl","year":"2014","journal-title":"Cell Calcium"},{"key":"10.1016\/j.bja.2022.08.029_bib21","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/ALN.0b013e31828cebfe","article-title":"Skeletal muscle ryanodine receptor mutations associated with malignant hyperthermia showed enhanced intensity and sensitivity to triggering drugs when expressed in human embryonic kidney cells","volume":"119","author":"Sato","year":"2013","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2022.08.029_bib22","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.bja.2018.05.051","article-title":"A\u00a0genetic mystery in malignant hyperthermia \u2018solved","volume":"121","author":"Schiemann","year":"2018","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2022.08.029_bib23","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1080\/23328940.2016.1153360","article-title":"Functional analysis of RYR1 variants linked to malignant hyperthermia","volume":"3","author":"Stephens","year":"2016","journal-title":"Temperature (Austin)"},{"key":"10.1016\/j.bja.2022.08.029_bib24","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1177\/0310057X1103900514","article-title":"Safety of exposure of malignant hyperthermia non-susceptible patients and their relatives to anaesthetic triggering agents","volume":"39","author":"Pollock","year":"2011","journal-title":"Anaesth Intensive Care"},{"key":"10.1016\/j.bja.2022.08.029_bib25","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/jmedgenet-2019-106461","article-title":"Investigating the genetic susceptibility to exertional heat illness","volume":"57","author":"Gardner","year":"2020","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.bja.2022.08.029_bib26","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ab.2007.11.019","article-title":"Identification of ryanodine receptor 1 single-nucleotide polymorphisms by high-resolution melting using the LightCycler 480 System","volume":"374","author":"Grievink","year":"2008","journal-title":"Anal Biochem"},{"key":"10.1016\/j.bja.2022.08.029_bib27","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1097\/ALN.0b013e3181d69283","article-title":"Functional studies of RYR1 mutations in the skeletal muscle ryanodine receptor using human RYR1 complementary DNA","volume":"112","author":"Sato","year":"2010","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2022.08.029_bib28","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.ajhg.2016.08.016","article-title":"REVEL: an ensemble method for predicting the pathogenicity of rare missense variants","volume":"99","author":"Ioannidis","year":"2016","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.bja.2022.08.029_bib29","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.bja.2018.06.028","article-title":"Genetic epidemiology of malignant hyperthermia in the UK","volume":"121","author":"Miller","year":"2018","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2022.08.029_bib30","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/s41436-021-01125-w","article-title":"Variant curation expert panel recommendations for RYR1 pathogenicity classifications in malignant hyperthermia susceptibility","volume":"23","author":"Johnston","year":"2021","journal-title":"Genet Med"},{"key":"10.1016\/j.bja.2022.08.029_bib31","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1093\/hmg\/9.10.1515","article-title":"A\u00a0novel ryanodine receptor mutation and genotype-phenotype correlation in a large malignant hyperthermia New Zealand Maori pedigree","volume":"9","author":"Brown","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.bja.2022.08.029_bib32","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1016\/j.bja.2021.05.008","article-title":"RYR1 variant c.38T>G, p.Leu13Arg causes hypersensitivity of the ryanodine receptor-1 and is pathogenic for malignant hyperthermia","volume":"127","author":"van den Bersselaar","year":"2021","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2022.08.029_bib33","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/bja\/aex042","article-title":"Assessing the pathogenicity of RYR1 variants in malignant hyperthermia","volume":"118","author":"Merritt","year":"2017","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2022.08.029_bib34","first-page":"51","article-title":"Identification and functional analysis of RYR1 variants in a family with a suspected myopathy and associated malignant hyperthermia","volume":"7","author":"Schiemann","year":"2020","journal-title":"J\u00a0Neuromuscul Dis"},{"key":"10.1016\/j.bja.2022.08.029_bib35","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1136\/jmg.2003.014274","article-title":"RYR1 mutations in UK central core disease patients: more than just the C-terminal transmembrane region of the RYR1 gene","volume":"41","author":"Shepherd","year":"2004","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.bja.2022.08.029_bib36","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0143-4160(02)00138-0","article-title":"Mutations in the RYR1 gene in Italian patients at risk for malignant hyperthermia: evidence for a cluster of novel mutations in the C-terminal region","volume":"32","author":"Galli","year":"2002","journal-title":"Cell Calcium"},{"key":"10.1016\/j.bja.2022.08.029_bib37","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/humu.9442","article-title":"Frequency and localization of mutations in the 106 exons of the RYR1 gene in 50 individuals with malignant hyperthermia","volume":"27","author":"Galli","year":"2006","journal-title":"Hum Mutat"},{"key":"10.1016\/j.bja.2022.08.029_bib38","doi-asserted-by":"crossref","first-page":"19225","DOI":"10.1073\/pnas.0504334102","article-title":"Interaction between the dihydropyridine receptor Ca2+ channel beta-subunit and ryanodine receptor type 1 strengthens excitation-contraction coupling","volume":"102","author":"Cheng","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bja.2022.08.029_bib39","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1096\/fj.05-4497fje","article-title":"Heat- and anesthesia-induced malignant hyperthermia in an RyR1 knock-in mouse","volume":"20","author":"Chelu","year":"2006","journal-title":"FASEB J"},{"key":"10.1016\/j.bja.2022.08.029_bib40","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.bja.2018.07.008","article-title":"Malignant hyperthermia, environmental heat stress, and intracellular calcium dysregulation in a mouse model expressing the p.G2435R variant of RYR1","volume":"121","author":"Lopez","year":"2018","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2022.08.029_bib41","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1085\/jgp.201010523","article-title":"Muscle weakness in Ryr1I4895T\/WT knock-in mice as a result of reduced ryanodine receptor Ca2+ ion permeation and release from the sarcoplasmic reticulum","volume":"137","author":"Loy","year":"2010","journal-title":"J\u00a0Gen Physiol"},{"key":"10.1016\/j.bja.2022.08.029_bib42","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1074\/jbc.M111.307926","article-title":"Gene dose influences cellular and calcium channel dysregulation in heterozygous and homozygous T4826I-RYR1 malignant hyperthermia-susceptible muscle","volume":"287","author":"Barrientos","year":"2012","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.bja.2022.08.029_bib43","doi-asserted-by":"crossref","first-page":"5361","DOI":"10.1113\/jphysiol.2011.216408","article-title":"Defects in Ca2+ release associated with local expression of pathological ryanodine receptors in mouse muscle fibres","volume":"589","author":"Lefebvre","year":"2011","journal-title":"J\u00a0Physiol"}],"container-title":["British Journal of Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091222004962?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091222004962?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T19:03:22Z","timestamp":1757790202000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007091222004962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S0007091222004962"],"URL":"https:\/\/doi.org\/10.1016\/j.bja.2022.08.029","relation":{},"ISSN":["0007-0912"],"issn-type":[{"value":"0007-0912","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functional analysis of RYR1 variants in patients with confirmed susceptibility to malignant hyperthermia","name":"articletitle","label":"Article Title"},{"value":"British Journal of Anaesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bja.2022.08.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 British Journal of Anaesthesia. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}